STEROID-REFRACTORY PNEUMONITIS

Clinical trials for STEROID-REFRACTORY PNEUMONITIS explained in plain language.

Never miss a new study

Get alerted when new STEROID-REFRACTORY PNEUMONITIS trials appear

Sign up with your email to follow new studies for STEROID-REFRACTORY PNEUMONITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

Race to tame deadly side effect of promising cancer drugs

Disease control Terminated

This study aimed to find a better treatment for a serious lung inflammation that can occur as a side effect of certain cancer immunotherapies when standard steroid treatment fails. It tested two different drug combinations (infliximab or intravenous immunoglobulin) in cancer pati…

Matched conditions: STEROID-REFRACTORY PNEUMONITIS

Phase: PHASE2 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control

Last updated Mar 20, 2026 14:47 UTC

STEROID-REFRACTORY PNEUMONITIS

Get alerted when new STEROID-REFRACTORY PNEUMONITIS trials appear

Race to tame deadly side effect of promising cancer drugs